01.17.25 -- Allogene's Mission To Democratize CAR-T

An alternative to traditional polyethylene bags is offering cell and gene therapy manufacturers a solution to contamination concerns regarding DNA or RNA fragments.

Dual sourcing strengthens the pharmaceutical supply chain for single-use assemblies. Learn how this strategy and multi-sourcing can enhance resilience and adaptability in the face of disruptions.

Explore how clinicians are tackling challenges in developing AAV vectors for use in gene therapy, working around hurdles to help these vectors meet their full potential to treat rare diseases.

Explore the findings of a survey of 124 U.S. oncologists focused on better understanding the current use of cell and gene therapies (CGTs) and possible barriers to future adoption.

AI has great potential to enhance the efforts of your team members by accelerating data interactions. Watch this webinar and discover how AI can improve clinical trial outcomes and data management.

Many patients are seeing cell or gene therapy treatments for their disease entering clinical trials. Review these rapidly changing advanced therapies and the post-pandemic pressures they face.